Suppr超能文献

丙型肝炎病毒亚基因组复制子对α干扰素、γ干扰素、聚肌苷酸-聚胞苷酸、肿瘤坏死因子α和利巴韦林的抗病毒作用及病毒-宿主相互作用

Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.

作者信息

Lanford Robert E, Guerra Bernadette, Lee Helen, Averett Devron R, Pfeiffer Brad, Chavez Deborah, Notvall Lena, Bigger Catherine

机构信息

Department of Virology and Immunology, Southwest National Primate Research Center, Southwest Foundation for Biomedical Research, San Antonio, Texas 78227, USA.

出版信息

J Virol. 2003 Jan;77(2):1092-104. doi: 10.1128/jvi.77.2.1092-1104.2003.

Abstract

The recently developed hepatitis C virus (HCV) subgenomic replicon system was utilized to evaluate the efficacy of several known antiviral agents. Cell lines that persistently maintained a genotype 1b replicon were selected. The replicon resident in each cell line had acquired adaptive mutations in the NS5A region that increased colony-forming efficiency, and some replicons had acquired NS3 mutations that alone did not enhance colony-forming efficiency but were synergistic with NS5A mutations. A replicon constructed from the infectious clone of the HCV-1 strain (genotype 1a) was not capable of inducing colony formation even after the introduction of adaptive mutations identified in the genotype 1b replicon. Alpha interferon (IFN-alpha), IFN-gamma, and ribavirin exhibited antiviral activity, while double-stranded RNA (dsRNA) and tumor necrosis factor alpha did not. Analysis of transcript levels for a series of genes stimulated by IFN (ISGs) or dsRNA following treatment with IFN-alpha, IFN-gamma, and dsRNA revealed that both IFNs increased ISG transcript levels, but that some aspect of the dsRNA response pathway was defective in Huh7 cells and replicon cell lines in comparison to primary chimpanzee and tamarin hepatocytes. The colony-forming efficiency of the replicon was reduced or eliminated following replication in the presence of ribavirin, implicating the induction of error-prone replication. The potential role of error-prone replication in the synergy observed between IFN-alpha and ribavirin in attaining sustained viral clearance is discussed. These studies reveal characteristics of Huh7 cells that may contribute to their unique capacity to support HCV RNA synthesis and demonstrate the utility of the replicon system for mechanistic studies on antiviral agents.

摘要

利用最近开发的丙型肝炎病毒(HCV)亚基因组复制子系统评估了几种已知抗病毒药物的疗效。选择了持续维持1b基因型复制子的细胞系。每个细胞系中的复制子在NS5A区域获得了适应性突变,从而提高了集落形成效率,并且一些复制子获得了NS3突变,这些突变单独不会提高集落形成效率,但与NS5A突变具有协同作用。即使引入了在1b基因型复制子中鉴定出的适应性突变,由HCV-1株(1a基因型)的感染性克隆构建的复制子仍无法诱导集落形成。α干扰素(IFN-α)、γ干扰素和利巴韦林表现出抗病毒活性,而双链RNA(dsRNA)和肿瘤坏死因子α则没有。在用IFN-α、IFN-γ和dsRNA处理后,对一系列受IFN刺激的基因(ISG)或dsRNA的转录水平进行分析,结果显示两种干扰素均增加了ISG转录水平,但与原代黑猩猩和绢毛猴肝细胞相比,Huh7细胞和复制子细胞系中dsRNA反应途径的某些方面存在缺陷。在利巴韦林存在的情况下复制后,复制子的集落形成效率降低或消除,这意味着诱导了易出错的复制。讨论了易出错复制在IFN-α和利巴韦林协同作用以实现持续病毒清除中所观察到的潜在作用。这些研究揭示了Huh7细胞的特性,这些特性可能有助于其支持HCV RNA合成的独特能力,并证明了复制子系统在抗病毒药物机制研究中的实用性。

相似文献

2
Replication studies using genotype 1a subgenomic hepatitis C virus replicons.
J Virol. 2003 May;77(9):5352-9. doi: 10.1128/jvi.77.9.5352-5359.2003.
3
Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA.
J Viral Hepat. 2004 Nov;11(6):479-87. doi: 10.1111/j.1365-2893.2004.00531.x.
5
Hepatitis C virus genotype 1b chimeric replicon containing genotype 3 NS5A domain.
Virology. 2006 Nov 25;355(2):192-202. doi: 10.1016/j.virol.2006.07.019. Epub 2006 Aug 21.
6
Effect of alpha interferon on the hepatitis C virus replicon.
J Virol. 2001 Sep;75(18):8516-23. doi: 10.1128/jvi.75.18.8516-8523.2001.
7
Interferon-alpha and ribavirin resistance of Huh7 cells transfected with HCV subgenomic replicon.
Virus Res. 2007 Apr;125(1):109-13. doi: 10.1016/j.virusres.2006.12.007. Epub 2007 Jan 24.
8
10
In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus.
Antimicrob Agents Chemother. 2014 Aug;58(8):4431-42. doi: 10.1128/AAC.02777-13. Epub 2014 May 27.

引用本文的文献

1
Comparison of Antiviral Immune Responses in Healthy Cats Induced by Two Immune Therapeutics.
Pathogens. 2024 Jul 22;13(7):602. doi: 10.3390/pathogens13070602.
2
Rift Valley Fever Virus Nucleoprotein Triggers Autophagy to Dampen Antiviral Innate Immune Responses.
J Virol. 2023 Apr 27;97(4):e0181422. doi: 10.1128/jvi.01814-22. Epub 2023 Mar 20.
4
Favipiravir Inhibits Hepatitis A Virus Infection in Human Hepatocytes.
Int J Mol Sci. 2022 Feb 27;23(5):2631. doi: 10.3390/ijms23052631.
5
An Immunomodulatory Transcriptional Signature Associated With Persistent Infection in Hepatocytes.
Front Cell Infect Microbiol. 2021 Nov 10;11:761945. doi: 10.3389/fcimb.2021.761945. eCollection 2021.
8
The Multifarious Role of 14-3-3 Family of Proteins in Viral Replication.
Viruses. 2020 Apr 13;12(4):436. doi: 10.3390/v12040436.
9
Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
J Virol. 2019 Sep 12;93(19). doi: 10.1128/JVI.00733-19. Print 2019 Oct 1.
10
Essential Role of Interferon Response in Containing Human Pathogenic Bourbon Virus.
Emerg Infect Dis. 2019 Jul;25(7):1304-1313. doi: 10.3201/eid2507.181062.

本文引用的文献

3
Mechanism of action of ribavirin in the combination treatment of chronic HCV infection.
Hepatology. 2002 May;35(5):1002-9. doi: 10.1053/jhep.2002.32672.
4
Persistent and transient replication of full-length hepatitis C virus genomes in cell culture.
J Virol. 2002 Apr;76(8):4008-21. doi: 10.1128/jvi.76.8.4008-4021.2002.
5
Regulation of PKR and IRF-1 during hepatitis C virus RNA replication.
Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4650-5. doi: 10.1073/pnas.062055699. Epub 2002 Mar 19.
6
Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs.
Hepatology. 2002 Mar;35(3):694-703. doi: 10.1053/jhep.2002.31770.
8
Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice.
J Virol. 2002 Mar;76(6):2617-21. doi: 10.1128/jvi.76.6.2617-2621.2002.
9
Advances in model systems for hepatitis C virus research.
Virology. 2002 Feb 1;293(1):1-9. doi: 10.1006/viro.2001.1316.
10
Treatment of acute hepatitis C with interferon alfa-2b.
N Engl J Med. 2001 Nov 15;345(20):1452-7. doi: 10.1056/NEJMoa011232.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验